| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0015 | 1 |